Effect of fluocinolone acetonide 0.2 μg/day implant on the decision to drive in patients with diabetic macular oedema: a report from the FAME study.
Dilraj S GrewalDonald C FletcherSeenu M HariprasadIvan J SunerPublished in: BMJ open ophthalmology (2019)
This post hoc analysis demonstrates a significant association between clinical outcomes in diabetic macular oedema and improvement in quality of life measures following a single FAc implant.